Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: A case report

Amnon Hadar, Eyal Sheiner, Fernanda Press, Amos Katz, Miriam Katz

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

BACKGROUND: Hodgkin's disease occurs frequently in women of reproductive age. Anthracyclines in general and doxorubicin in particular are integral parts of therapy. CASE: A 24-year-old primigravida had dilated cardiomyopathy diagnosed at 34 weeks' gestation. Three years earlier she had been treated with chest radiation and combination chemotherapy, including doxorubicin, for Hodgkin's disease. CONCLUSION: The clinician should be aware of this manifestation. Multidisciplinary supervision throughout pregnancy as well as planned timing and mode of delivery are mandatory.

Original languageEnglish
Pages (from-to)401-403
Number of pages3
JournalThe Journal of reproductive medicine
Volume49
Issue number5
StatePublished - 1 May 2004
Externally publishedYes

Keywords

  • Dilated cardiomyopathy
  • Doxorubicin
  • Hodgkin disease
  • Pregnancy complications, cardiovascular
  • Radiotherapy

Fingerprint

Dive into the research topics of 'Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: A case report'. Together they form a unique fingerprint.

Cite this